Diabetes Stocks List

Diabetes Stocks Recent News

Date Stock Title
Jan 31 NVO Novo Nordisk FY 2022 Earnings Preview
Jan 31 NVO J&J (JNJ) Down as Court Rejects Bankruptcy Claim in Talc Lawsuits
Jan 31 INBS Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests
Jan 31 BDX BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year
Jan 31 NVO Can Sanofi (SNY) Keep the Beat Streak Alive in Q4 Earnings?
Jan 31 PETS Pets at Home sees FY 2023 underlying pretax profit at upper end of consensus
Jan 31 ASND What Makes Ascendis Pharma A/S (ASND) an Attractive Investment Choice?
Jan 30 NVO U.S. Appeals Court Sides With Drugmakers on Discount Program
Jan 30 NVO UPDATE 1-Drugmakers prevail in dispute over U.S. discount drug program
Jan 30 NVO Drugmakers prevail in dispute over U.S. discount drug program
Jan 30 BDX BD (BDX) Gears Up for Q1 Earnings: What's in the Offing?
Jan 30 NVO Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod
Jan 30 BDX Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?
Jan 30 NVO Merck (MRK) to Report Q4 Earnings: What's in the Cards?
Jan 30 CBAY CymaBay Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 30 PETS Is PetMed Express, Inc.'s (NASDAQ:PETS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 30 NVO Beat the Market the Zacks Way: NVIDIA, Bilibili, Novo Nordisk in Focus
Jan 29 EHAB Enhabit: Difficult Time Ahead According To Market Generated Data (Technical Analysis)
Jan 27 ASND Ascendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral Rating
Jan 27 NVO Weibo and Viasat have been highlighted as Zacks Bull and Bear of the Day

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags